Chemoinformaics analysis of 4-HEXEN-1-OL, (4Z)-
| Molecular Weight | 100.161 | nRot | 3 |
| Heavy Atom Molecular Weight | 88.065 | nRig | 1 |
| Exact Molecular Weight | 100.089 | nRing | 0 |
| Solubility: LogS | -0.696 | nHRing | 0 |
| Solubility: LogP | 1.453 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 18.8235 |
| nHD | 1 | BPOL | 12.0385 |
| QED | 0.419 |
| Synth | 2.613 |
| Natural Product Likeliness | 2.42 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.089 |
| HIA | 0.005 |
| CACO-2 | -4.148 |
| MDCK | 0.0000468 |
| BBB | 0.962 |
| PPB | 0.322166 |
| VDSS | 0.885 |
| FU | 0.707816 |
| CYP1A2-inh | 0.372 |
| CYP1A2-sub | 0.484 |
| CYP2c19-inh | 0.041 |
| CYP2c19-sub | 0.536 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.592 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.192 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.167 |
| CL | 10.221 |
| T12 | 0.836 |
| hERG | 0.009 |
| Ames | 0.029 |
| ROA | 0.028 |
| SkinSen | 0.617 |
| Carcinogencity | 0.242 |
| EI | 0.994 |
| Respiratory | 0.041 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.956833 |